Parkside Financial Bank & Trust’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
Other funds holding EBS
Parkside Financial Bank & Trust's EBS Position: Q3 2023 in Review
Parkside Financial Bank & Trust sold out of Emergent Biosolutions (EBS) in Q3 2023, closing a stake of 470 shares — an estimated $3.46K sold.
Parkside Financial Bank & Trust first reported a position in EBS in Q4 2016 and held it in 20 quarters. The position peaked at $9K in Q4 2021. 162 funds tracked by Wall St. Rank hold EBS as of Q3 2023.
- Parkside Financial Bank & Trust reported no remaining Emergent Biosolutions position as of Q3 2023 after selling out during the quarter.
- Parkside Financial Bank & Trust sold 470 Emergent Biosolutions shares in Q3 2023, an estimated $3.46K.
- Parkside Financial Bank & Trust first reported a position in Emergent Biosolutions in Q4 2016 and held it in 20 quarters.
- Parkside Financial Bank & Trust's Emergent Biosolutions position peaked at $9K in Q4 2021.
- 162 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2023.
Based on Parkside Financial Bank & Trust's 13F filing for Q3 2023, filed 13 Nov 2023.